Management of Migraine in a Patient with Chronic Uncontrolled Hypertension

Assessment and Treatment of Hypertension

The American College of Cardiology recommends metoprolol's target dose for hypertension is 200 mg daily, significantly higher than the patient's current dose of 25 mg BID 4
The American College of Cardiology suggests lisinopril's target dose for hypertension ranges from 20-40 mg daily, higher than the current 10 mg dose 4
The British Medical Journal recommends optimizing current antihypertensive therapy, including increasing metoprolol to target dose of 200 mg daily and lisinopril to 20-40 mg daily 3, 4

The American Academy of Family Physicians states that triptans are contraindicated in patients with uncontrolled hypertension due to their vasoconstrictive properties 5
The American College of Cardiology recommends topiramate (25-200 mg daily) as first-line prophylactic therapy for migraine, with established efficacy in chronic migraine and no adverse effect on blood pressure 1, 2
The American Academy of Family Physicians suggests dihydroergotamine intranasal formulation as a safer option for acute treatment in patients with uncontrolled hypertension 5

The Mayo Clinic recommends implementing relaxation techniques, biofeedback, and cognitive behavioral therapy to benefit both migraine and hypertension 1, 2
The Mayo Clinic suggests encouraging regular exercise, which benefits both migraine and hypertension, and maintaining a headache diary to identify triggers 1, 2

The American Heart Association, as published in Circulation, recommends being aware that some migraine preventive medications may interact with the patient's current antihypertensive regimen 8
The American Academy of Family Physicians states that establishing realistic expectations with the patient is crucial, as prophylactic benefits may take 2-3 months to become apparent 5